Analysis of drug uptake-flow cytometry.
Zoorob
G
G
Division of Medicinal Chemistry and Phamaceutics, College of Pharmacy, University of Kentucky, Lexington, USA.
Burke
T
T
D018943:Anthracyclines / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D001692:Biological Transport; D002166:Camptothecin / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D003630:Daunorubicin / Q000378:metabolism; D018432:Drug Resistance, Multiple; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D004912:Erythrocytes / Q000378:metabolism*; D005434:Flow Cytometry / Q000295:instrumentation / Q000379:methods*; D005456:Fluorescent Dyes / Q000378:metabolism; D007700:Kinetics; D008081:Liposomes / Q000737:chemistry / Q000378:metabolism; D015394:Molecular Structure; D011355:Prodrugs / Q000737:chemistry / Q000378:metabolism; D012709:Serum Albumin / Q000494:pharmacology; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors
D018943:Anthracyclines; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D005456:Fluorescent Dyes; D008081:Liposomes; D011355:Prodrugs; D012709:Serum Albumin; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D002166:Camptothecin; D003630:Daunorubicin